Hematology and Hemostasis
Hematology and hemostasis is the area of clinical laboratory science concerned with the analysis of blood cells and the testing of the clotting system. It groups the everyday quantitative measurements of red cells, white cells, and platelets together with the morphological review of blood films and the functional assays that probe coagulation and platelet behaviour, providing much of the laboratory evidence used in the recognition and monitoring of anaemias, bleeding disorders, and thrombotic states.
Definition
Hematology and hemostasis denotes the laboratory testing of blood cells (their number, size, and morphology) and of the hemostatic system (coagulation factor function, fibrin formation, and platelet activity), encompassing both screening tests and confirmatory assays used to investigate disorders of blood and clotting.
Scope
The area orients the reader across two linked domains: the cellular side, where automated counters and the peripheral blood film characterise the formed elements of blood, and the hemostatic side, where clot-based, immunological, and aggregation assays describe how blood clots and how that process can fail. It is a reference and educational overview of the laboratory discipline and its constituent topics, not a source of diagnostic thresholds or treatment guidance.
Sub-topics
Core questions
- What do automated cell counts and the blood film together reveal about the formed elements of blood?
- How do screening coagulation tests localise a defect in the clotting system, and when are confirmatory assays required?
- How is platelet function distinguished from platelet number in the laboratory?
- How does the laboratory assemble cellular and hemostatic findings to characterise anaemia or a bleeding or clotting tendency?
Key concepts
- Complete blood count and differential
- Peripheral blood film and red cell indices
- Coagulation cascade and clot-based screening
- Platelet count versus platelet function
- Hemolysis and its laboratory markers
- Standardization and reference ranges in laboratory hematology
Mechanisms
The cellular workstream begins with an automated analyser that enumerates and sizes blood cells and computes red cell indices; abnormal or flagged results trigger a microscopic review of the stained blood film, for which the ICSH has standardised nomenclature and grading (Palmer, 2015). The hemostatic workstream rests on the recognition that coagulation proceeds on cell surfaces in vivo (Monroe, 2001), while the laboratory reproduces fibrin formation in clot-based screening tests and probes platelet responses with aggregation assays standardised by international consensus (Cattaneo, 2013). When hemolysis is suspected, a panel of markers such as reticulocyte count, lactate dehydrogenase, haptoglobin, and bilirubin, together with the direct antiglobulin test, is used to characterise red cell destruction (Barcellini, 2015).
Clinical relevance
Tests in this area underlie the laboratory recognition and monitoring of a broad range of conditions, including the anaemias, leukocyte and platelet disorders, inherited and acquired bleeding tendencies, and thrombotic states. The entry describes how such laboratory evidence is generated and standardised; it is educational and is not a basis for individual diagnostic or treatment decisions.
Evidence & guidelines
Standardization in this area is shaped by international bodies, notably the International Council for Standardization in Haematology (ICSH) for blood film nomenclature and grading (Palmer, 2015) and the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (SSC/ISTH) for platelet aggregometry (Cattaneo, 2013). Review syntheses such as Barcellini (2015) describe how hemolytic markers are combined in differential diagnosis.
Related topics
Seminal works
- palmer-2015
- cattaneo-2013
- barcellini-2015
Frequently asked questions
- How does hematology testing differ from hemostasis testing?
- Hematology testing characterises the blood cells themselves, including their number, size, and morphology, while hemostasis testing characterises the clotting system, including coagulation factor function, fibrin formation, and platelet activity. The two are grouped together because both are performed on blood and are frequently interpreted alongside each other.
- Why is a blood film still examined when automated counters exist?
- Automated analysers enumerate and size cells efficiently, but they cannot fully characterise abnormal cell morphology; flagged or abnormal results prompt a microscopic review of the stained film, for which standardised nomenclature and grading have been published.